Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy

Trial Profile

Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Mar 2017

At a glance

  • Drugs ANB 020 (Primary)
  • Indications Asthma; Peanut hypersensitivity
  • Focus Proof of concept; Therapeutic Use
  • Sponsors AnaptysBio
  • Most Recent Events

    • 04 Mar 2017 According to AnaptysBio media release, top line data from this study are anticipated during the second half of 2017.
    • 03 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 13 Dec 2016 According to AnaptysBio media release, US FDA has cleared the investigational new drug application (IND) to initiate this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top